CRT 2026

INNOVATORS IN ACTION | EMERGING IDEAS SHAPING THE FUTURE | SESSION I

Moderator(s)

• 

  Gary M. Ansel, MD, FACC

  Founder
  Healthcare Inroads
  Columbus , Ohio, United States

  Disclosure information not submitted.
• 

  Rafael Beyar, MD, DSc, MPH

  Interventional cardiologists and President
  Rambam Hospital/ Rambam Friends Organizations
  Haifa, Israel

  Disclosure(s): ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)
• 

  Nabil Dib, MD, MSc, FACC

  Director Cardiovascular Research
  Mercy Gilbert Medical Center/Dignity Health
  Gilbert, Arizona, United States

  Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

• 

  Nicolas Foin, MSc, PhD

  Adj Associate Professor
  Duke-NUS Medical School
  Brussels, Brussels Hoofdstedelijk Gewest, Belgium

  Disclosure information not submitted.
• 

  Robert J. Lederman, MD

  Senior Investigator, Chief, Laboratory of Cardiovascular Intervention
  National Institutes of Health/National Heart, Lung, and Blood Institute
  Bethesda, Maryland, United States

  Disclosure(s): National Institutes of Health: Grant/Research Support (Ongoing), I am co-inventor on patent applications assigned to NIH (my employer) (Ongoing)
• 

  Tilak K. R Pasala, MD

  Medical Director, Structural Heart Program
  Delray Medical Center
  Delray Beach, Florida, United States

  Disclosure(s): Edward Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Ronald J. Solar, PhD, FESC

  President
  Renaissance Biomedical, Inc.
  San Diego, California, United States

  Disclosure(s): Micromedical Solutions: Stock Options [in privately held companies] (Ongoing)